Research & Development Market Research Reports & Industry Analysis

Research and development activities are the heart of the pharmaceutical industry’s value creation. R&D fuels the product pipeline but takes its fair share of the expense side of the balance sheet. It is estimated that bringing a successful drug to market from discovery through development to market launch costs well in excess of US$1 billion.

Bringing R&D costs and times down, therefore, means there are many opportunities to improve efficiencies, advance technological innovation, and economize and optimize. The pharmaceutical R&D category tracks both drug pipeline reports, competitive R&D strategies, and markets important and ancillary to the research efforts themselves, including activities in the biotech and sector that impinge upon the process.

...Show More ...Show Less


Research & Development Industry Research & Market Reports

  • Global Agriculture Synthetic Biology Market Growth (Status and Outlook) 2024-2030

    ... reaching a systematic reconstruction of genetic and metabolic systems. However, there has been commercialization in areas such as designed breeding, nitrogen-fixing fertilizers, and microbial pesticides. Overall, the field is evolving and advancing with ongoing developments ... Read More

  • Global Biotechnology - Industry Market Research Report

    ... COVID-19 brought more attention to biotechnology, as biotech companies were central to vaccine development and reopening the economy. Biotech's potential to develop vaccines shifted the industry's trajectory, with investment reaching unprecedented levels globally and spurring ... Read More

  • Scientific Research & Development in the US - Industry Market Research Report

    ... that undertake R&D to support their primary operations, like pharmaceutical corporations and government entities, aren't included in this industry. Revenue for the scientific research and development industry increased an annualized 2.3% to $223.7 billion over ... Read More

  • Biotechnology in the UK - Industry Market Research Report

    ... Biotechnology industry is fast becoming a prominent part of the UK life science sector, alongside pharmaceutical and medical technology companies. The convergence of these three technologies makes it increasingly difficult to identify the boundaries between ... Read More

  • 2024 Organ Bank Services Global Market Size & Growth Report with Updated Analysis & Forecasts

    ... 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 195 countries. Figures are from 2012 through 2023, with forecasts for 2024 and 2028. The historical data utilizes in-depth ... Read More

  • White Biotech Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War

    ... 2025-2034. This report on global white biotech market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global white ... Read More

  • Synthetic Biology Market Size, Share & Trends Analysis Report By Product (Enzymes, Cloning Technologies Kits), By Technology (PCR, NGS), By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030

    ... Growth & Trends The global synthetic biology market size is expected to reach USD 42.06 billion by 2030, registering a CAGR of 17.30% 2025 to 2030, according to a new report by Grand View Research, ... Read More

  • Lab Consumables Market by Type (Microplate, Pipette & Tip, Tube, Filter, Vial, Gloves), Application (Research, Diagnostic, Industrial manufacturing, Forensic, Material, Environmental), End User (Hospital, Pharma, Biotech, F&B) - Global Forecast to 2029

    ... consumables market is projected to reach USD 20.51 billion by 2029 from USD 14.41 billion in 2024, growing at a CAGR of 7.3% during the forecast period. The technological advancements of lab consumables products is ... Read More

  • Global Synthetic Biology Market - Focused Insights 2024-2029

    ... Products Synthetic biology is revolutionizing real-world applications across multiple industries, including food, pharmaceuticals, and agriculture. From 2000 to 2021, significant advances in synthetic biology tools have enabled biotechnology, pharmaceutical, and agriculture companies to develop innovative ... Read More

  • Biotech Research and Development - US Industry Market Research Report with Updated Analysis & Forecasts

    ... the industry in the United States with over 100+ data sets covering 2015-2028. This Kentley Insights report is full of industry insights including historical and forecasted market size, revenue and industry breakdowns by product lines, ... Read More

  • 2024 Biotech Research and Development Global Market Size & Growth Report with Updated Recession Risk Forecasts

    ... across 4 global regions, 22 subregions, and 195 countries. Historical data is from 2012 through 2023, with forecasts for 2024 and 2028. The historical data utilizes in-depth survey results from companies in the Biotech Research ... Read More

  • Healthcare Contract Development and Manufacturing Organization

    ... the year 2023, is expected to reach US$547.1 Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2023-2030. Contract Manufacturing, one of the segments analyzed in the report, is expected to ... Read More

  • Patient Derived Xenograft / PDX Models

    ... the year 2023, is expected to reach US$510.8 Million by 2030, growing at a CAGR of 16.3% over the analysis period 2023-2030. Pre-Clinical Drug Development Application, one of the segments analyzed in the report, is ... Read More

  • Genomics in Cancer Care

    ... reach US$62.1 Billion by 2030, growing at a CAGR of 16.5% over the analysis period 2023-2030. Instruments, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and reach US$25.0 ... Read More

  • Humanized Mouse and Rat Model

    ... is expected to reach US$219.4 Million by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Oncology Application, one of the segments analyzed in the report, is expected to record a 8.1% ... Read More

  • Soft Tissue Allografts

    ... at a CAGR of 4.9% over the analysis period 2023-2030. Orthopedic Application, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.9 Billion by the end of ... Read More

  • Cold Plasma

    ... at a CAGR of 14.7% over the analysis period 2023-2030. Polymer & Plastics End-Use, one of the segments analyzed in the report, is expected to record a 13.9% CAGR and reach US$1.7 Billion by the ... Read More

  • Biotech Business October 2024

    ... on biotechnology products and companies. It reports which universities offer licensing of biotechnology research, which companies have entered licensing agreements, as well as the financial health of biotechnology companies and their expected growth or decline. Read More

  • PEGylated Proteins

    ... at a CAGR of 9.1% over the analysis period 2023-2030. PEGylated Protein Consumables, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$1.3 Billion by the end ... Read More

  • Peptide Synthesis

    ... at a CAGR of 4.3% over the analysis period 2023-2030. Reagent, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$161.7 Million by the end of the ... Read More

  • Human Liver Models

    ... by 2030, growing at a CAGR of 9.5% over the analysis period 2023-2030. Drug Discovery Application, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$225.8 Million ... Read More

  • Neuroscience

    ... of 3.8% over the analysis period 2023-2030. Instruments Component, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$29.9 Billion by the end of the analysis period. ... Read More

  • Albumin

    ... of 3.7% over the analysis period 2023-2030. Human Serum Albumin, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$902.4 Million by the end of the analysis ... Read More

  • Immune Checkpoint Inhibitors

    ... by 2030, growing at a CAGR of 16.5% over the analysis period 2023-2030. Lung Cancer, one of the segments analyzed in the report, is expected to record a 16.7% CAGR and reach US$69.3 Billion by ... Read More

  • Cancer Immunotherapy

    ... at a CAGR of 13.6% over the analysis period 2023-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 14.4% CAGR and reach US$266.2 Billion by the end of ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings